Sleep and 5-HT2 receptor sensitivity in recovered depressed patients.

The increase in slow wave sleep which followed administration of the 5-HT2 receptor antagonist, ritanserin, was not significantly different between a group of 12 recovered, drug free depressed patients and a group of 12 health matched controls. The results suggests that there is no underlying abnorm...

Full description

Bibliographic Details
Main Authors: da Roza Davis, J, Sharpley, A, Solomon, R, Cowen, P
Format: Journal article
Language:English
Published: 1992
_version_ 1797051922987876352
author da Roza Davis, J
Sharpley, A
Solomon, R
Cowen, P
author_facet da Roza Davis, J
Sharpley, A
Solomon, R
Cowen, P
author_sort da Roza Davis, J
collection OXFORD
description The increase in slow wave sleep which followed administration of the 5-HT2 receptor antagonist, ritanserin, was not significantly different between a group of 12 recovered, drug free depressed patients and a group of 12 health matched controls. The results suggests that there is no underlying abnormality in the 5-HT2 receptor regulation of slow wave sleep in recovered depressives, and that abnormalities in this measure reported previously in such patients may have been caused by use of concomitant tricyclic antidepressant medication. The baseline sleep parameters did not differ between recovered depressives and controls with the exception of stage 1 sleep, which was increased in the patient group.
first_indexed 2024-03-06T18:26:02Z
format Journal article
id oxford-uuid:07fd7d1a-8f80-4788-b169-248f2ec71f1f
institution University of Oxford
language English
last_indexed 2024-03-06T18:26:02Z
publishDate 1992
record_format dspace
spelling oxford-uuid:07fd7d1a-8f80-4788-b169-248f2ec71f1f2022-03-26T09:10:32ZSleep and 5-HT2 receptor sensitivity in recovered depressed patients.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:07fd7d1a-8f80-4788-b169-248f2ec71f1fEnglishSymplectic Elements at Oxford1992da Roza Davis, JSharpley, ASolomon, RCowen, PThe increase in slow wave sleep which followed administration of the 5-HT2 receptor antagonist, ritanserin, was not significantly different between a group of 12 recovered, drug free depressed patients and a group of 12 health matched controls. The results suggests that there is no underlying abnormality in the 5-HT2 receptor regulation of slow wave sleep in recovered depressives, and that abnormalities in this measure reported previously in such patients may have been caused by use of concomitant tricyclic antidepressant medication. The baseline sleep parameters did not differ between recovered depressives and controls with the exception of stage 1 sleep, which was increased in the patient group.
spellingShingle da Roza Davis, J
Sharpley, A
Solomon, R
Cowen, P
Sleep and 5-HT2 receptor sensitivity in recovered depressed patients.
title Sleep and 5-HT2 receptor sensitivity in recovered depressed patients.
title_full Sleep and 5-HT2 receptor sensitivity in recovered depressed patients.
title_fullStr Sleep and 5-HT2 receptor sensitivity in recovered depressed patients.
title_full_unstemmed Sleep and 5-HT2 receptor sensitivity in recovered depressed patients.
title_short Sleep and 5-HT2 receptor sensitivity in recovered depressed patients.
title_sort sleep and 5 ht2 receptor sensitivity in recovered depressed patients
work_keys_str_mv AT darozadavisj sleepand5ht2receptorsensitivityinrecovereddepressedpatients
AT sharpleya sleepand5ht2receptorsensitivityinrecovereddepressedpatients
AT solomonr sleepand5ht2receptorsensitivityinrecovereddepressedpatients
AT cowenp sleepand5ht2receptorsensitivityinrecovereddepressedpatients